Skip to content
The Policy VaultThe Policy Vault

Crenessity (crinecerfont)CareFirst (Caremark)

Classic congenital adrenal hyperplasia (CAH)

Initial criteria

  • Member is 4 years of age or older
  • Diagnosis of classic congenital adrenal hyperplasia (CAH) is confirmed by any of the following: genetic test confirming presence of pathogenic variants in CYP21A2 OR lab tests confirming 21-hydroxylase deficiency [e.g., baseline morning serum 17-hydroxyprogesterone (17-OHP) measurement by LC-MS/MS, cosyntropin (ACTH) stimulation test, adrenal steroid profile]
  • Member is currently receiving glucocorticoid therapy and stable for at least 1 month
  • Medication is prescribed by or in consultation with an endocrinologist
  • No diagnosis of other known forms of CAH (e.g., 11-beta-hydroxylase deficiency, 17-alpha-hydroxylase deficiency)
  • No history of bilateral adrenalectomy, hypopituitarism, or other condition requiring chronic glucocorticoid therapy

Reauthorization criteria

  • Member has achieved or maintained a positive clinical response to treatment (e.g., reduction in glucocorticoid therapy)

Approval duration

12 months